INS and type 2 diabetes mellitus: Consistent with the above described results, treatment with TAS and metformin significantly increased the serum INS and C-P levels and decreased the HOMA-IR, indicating that TAS can improve the function of islet cells and inhibit IR in T2DM in vivo.